Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Solid Tumors × avelumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 8 Carcinoma, Non-Small-Cell Lung 6 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Carcinoma, Transitional Cell 5 Squamous Cell Carcinoma of Head and Neck 4 Carcinoma, Renal Cell 4 Triple Negative Breast Neoplasms 3 Breast Neoplasms 3 Recurrence 2 Lymphoma 2 Colorectal Neoplasms 2 Central Nervous System Neoplasms 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Skin Neoplasms 1 Sezary Syndrome 1 Sarcoma 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Mycosis Fungoides 1 Metastatic Urothelial Cell Cancer 1 Metastatic Solid Tumors 1 Meningioma 1 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 Melanoma 1 Malignant Solid Tumour 1

Interventions

Injections 15 Carboplatin 14 Docetaxel 10 pembrolizumab 7 durvalumab 6 Cisplatin 6 linifanib 5 Paclitaxel 5 talazoparib 4 olaparib 4 Panobinostat 4 Nivolumab 4 Itraconazole 4 Bevacizumab 4 zimberelimab 3 sintilimab 3 depatuxizumab 3 atezolizumab 3 ST 1481 3 S 1 (combination) 3 Rifampin 3 Pemetrexed 3 Fluorouracil 3 trifluridine tipiracil drug combination 2 tremelimumab 2 tislelizumab 2 tesetaxel 2 spartalizumab 2 motesanib diphosphate 2 ixabepilone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02994953 2024-09-20

COMBO

EMD Serono

Phase 1 Terminated

52 enrolled 34 charts

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡